SEC 13F Intelligence

Foresite Capital Management Vi LLC / 260

Foresite Capital Management Vi LLC’s Centessa Pharmaceuticals PLC Position

Does Foresite Capital Management Vi LLC own Centessa Pharmaceuticals PLC (260)? Yes — 1.36M shares worth $54M (+11.77% of its 13F portfolio) as of Q1 2026.

Position Value
$54M
Q1 2026
Shares
1.36M
% of Portfolio
+11.77%
Quarters Held
6
currently held

Position History 260

Reported value by quarter
Q4 ’24: $21MQ4 ’24Q1 ’25: $18MQ1 ’25Q2 ’25: $16MQ2 ’25Q3 ’25: $32MQ3 ’25Q4 ’25: $34MQ4 ’25Q1 ’26: $54MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.36M$54M+11.77%
Q4 20251.36M$34M+10.31%
Q3 20251.31M$32M+12.31%
Q2 20251.25M$16M+9.26%
Q1 20251.25M$18M+9.87%
Q4 20241.25M$21M+9.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of 260.